Seven Eight Capital LP increased its holdings in Express Scripts Holding Co (NASDAQ:ESRX) by 19.0% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 92,680 shares of the company’s stock after purchasing an additional 14,800 shares during the quarter. Seven Eight Capital LP’s holdings in Express Scripts were worth $6,402,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. SeaCrest Wealth Management LLC purchased a new stake in shares of Express Scripts in the 4th quarter worth about $105,000. Aevitas Wealth Management Inc. purchased a new stake in shares of Express Scripts in the 4th quarter worth about $128,000. Financial Gravity Companies Inc. purchased a new stake in shares of Express Scripts in the 4th quarter worth about $142,000. ClariVest Asset Management LLC lifted its holdings in Express Scripts by 31,700.0% in the 1st quarter. ClariVest Asset Management LLC now owns 2,226 shares of the company’s stock valued at $153,000 after purchasing an additional 2,219 shares in the last quarter. Finally, Archford Capital Strategies LLC purchased a new position in Express Scripts in the 1st quarter valued at about $157,000. Institutional investors and hedge funds own 85.93% of the company’s stock.
In other news, insider Christine Houston sold 19,889 shares of the company’s stock in a transaction dated Thursday, March 15th. The shares were sold at an average price of $76.69, for a total transaction of $1,525,287.41. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.79% of the company’s stock.
NASDAQ ESRX opened at $76.53 on Thursday. Express Scripts Holding Co has a 12 month low of $55.80 and a 12 month high of $85.07. The company has a debt-to-equity ratio of 0.81, a current ratio of 0.69 and a quick ratio of 0.56. The stock has a market cap of $42.06 billion, a PE ratio of 10.78, a P/E/G ratio of 0.94 and a beta of 0.96.
Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings data on Wednesday, May 2nd. The company reported $1.77 EPS for the quarter, beating the Zacks’ consensus estimate of $1.76 by $0.01. Express Scripts had a net margin of 4.59% and a return on equity of 25.41%. The company had revenue of $24.77 billion during the quarter, compared to the consensus estimate of $24.80 billion. During the same quarter in the prior year, the company posted $1.33 EPS. The company’s quarterly revenue was up .5% compared to the same quarter last year. analysts expect that Express Scripts Holding Co will post 9.07 earnings per share for the current fiscal year.
ESRX has been the topic of a number of recent research reports. Maxim Group upped their target price on shares of Express Scripts from $87.00 to $101.00 in a report on Wednesday, February 28th. BidaskClub upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Friday, February 23rd. Jefferies Group set a $91.00 target price on shares of Express Scripts and gave the company a “buy” rating in a report on Wednesday, February 28th. Zacks Investment Research upgraded shares of Express Scripts from a “hold” rating to a “buy” rating and set a $82.00 target price on the stock in a report on Wednesday, February 14th. Finally, ValuEngine upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Thursday, April 26th. Four investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have issued a buy rating to the stock. Express Scripts currently has a consensus rating of “Hold” and a consensus price target of $82.50.
Express Scripts Profile
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.